Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBA of AZD5847 in Pulmonary Tuberculosis
NCT01516203Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posizolid in pulmonary tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2012; status: completed.
02
Drugs
posizolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01516203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516203.